mk-0472
Showing 1 - 1 of 1
Metastatic Solid Tumors, Advanced Solid Tumors Trial (MK-0472, Pembrolizumab)
Not yet recruiting
- Metastatic Solid Tumors
- Advanced Solid Tumors
- MK-0472
- Pembrolizumab
- (no location specified)
May 2, 2023